美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ArTara Therapeutics, Inc.

5.26

-0.1900-3.49%

成交量：16.57萬

成交額：87.10萬

市值：2.84億

市盈率：-3.92

高：5.46

開：5.40

低：5.18

收：5.45

52周最高：7.82

52周最低：2.77

股本：5,408.44萬

流通股本：3,546.20萬

量比：0.48

換手率：0.47%

股息：- -

股息率：- -

每股收益(TTM):-1.3409

每股收益(LYR):-1.3409

淨資產收益率：-31.60%

總資產收益率：-20.64%

市淨率：1.45

市盈率(LYR):-3.92

資料載入中...

總覽公司新聞資訊公告

ArTara Therapeutics預計2026年下半年完成BCG無應答隊列入組

ArTara Therapeutics公司按計劃將於2026年下半年啓動針對BCG初治患者的Advanced-3註冊試驗

Protara Therapeutics公布2025年第四季度及全年財務業績並更新業務進展

美國研究綜述-Crowdstrike、甲骨文、火神材料公司

BUZZ--美國股票走勢-Henry Schein、多米諾比薩、FactSet

BUZZ-抗癌藥物數據低於投資者預期，普羅塔拉股價暴跌

Protara Therapeutics Inc：安全性及耐受性表現良好，未出現3級或以上治療相關不良事件

ArTara Therapeutics, Inc.：按計劃推進於2026年下半年啓動針對BCG初治患者的Advanced-3期註冊試驗

ArTara Therapeutics公司：預計2026年下半年完成BCG無應答隊列的Advanced-2試驗入組

Tara-002在BCG無應答非肌層浸潤性膀胱癌中展現68%的六個月完全緩解率

Protara Therapeutics啓動靜脈氯化膽鹼三期關鍵性Thrive-3試驗首位長期腸外營養患者完成給藥

Protara Therapeutics旗下Tara-002獲FDA突破性療法與快速通道雙認定用於兒科淋巴管畸形治療

BUZZ--美國股票走勢-華納兄弟探索頻道、Ulta Beauty、維多利亞的秘密

BUZZ-生物技術公司 Protara 計劃融資 7500 萬美元，股價暴跌

ArTara Therapeutics, Inc.：Tara-002在BCG未治療患者的12個月裏顯示出50%的完全反應率

Protara Therapeutics: Tara-002在BCG未治療患者中的完全緩解率高達72%

Protara Therapeutics公布積極的中期結果，顯示在對患有淋巴畸形的兒童患者進行的Phase 2 Starborn-1試驗中Tara-002的強烈反應

ArTara Therapeutics, Inc.：88%的患者在接受一劑或兩劑Tara-002治療後取得臨床成功

ArTara Therapeutics, Inc.: Tara-002顯示出良好的安全性和耐受性，無嚴重不良事件報告

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TARA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TARA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TARA\",,,,,undefined,":{"symbol":"TARA","market":"US","secType":"STK","nameCN":"ArTara Therapeutics, Inc.","latestPrice":5.26,"timestamp":1773851849069,"preClose":5.45,"halted":0,"volume":165681,"delay":0,"changeRate":-0.03486238532110099,"floatShares":35462021,"shares":54084378,"eps":-1.3409,"marketStatus":"交易中","change":-0.19,"latestTime":"03-18 12:38:08 EDT","open":5.4,"high":5.455,"low":5.18,"amount":870981.3057456,"amplitude":0.050459,"askPrice":5.28,"askSize":45,"bidPrice":5.27,"bidSize":57,"shortable":3,"etf":0,"ttmEps":-1.3409,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"adr":0,"listingDate":1413950400000,"exchange":"NASDAQ","adjPreClose":5.45,"preHourTrading":{"tag":"盘前","latestPrice":5.41,"preClose":5.45,"latestTime":"07:26 EDT","volume":8,"amount":43.28,"timestamp":1773833210967,"change":-0.04,"changeRate":-0.007339,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"18:52 EDT","volume":17622,"amount":96018.8,"timestamp":1773787979774,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.484748,"impliedVol":1.5038,"impliedVolPercentile":0.6255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TARA\",,,,,undefined,":{"symbol":"TARA","floatShares":35462021,"roa":"-20.64%","roe":"-31.60%","lyrEps":-1.3409,"volumeRatio":0.484748,"shares":54084378,"dividePrice":0,"high":5.455,"amplitude":0.050459,"preClose":5.45,"low":5.18,"week52Low":2.77,"pbRate":"1.45","week52High":7.82,"institutionHeld":0,"latestPrice":5.26,"committee":0.117647,"eps":-1.3409,"divideRate":0,"volume":165681,"delay":0,"ttmEps":-1.3409,"open":5.4,"prevYearClose":5.33,"prevWeekClose":5.26,"prevMonthClose":6.36,"prevQuarterClose":5.33,"fiveDayClose":5.6,"twentyDayClose":6.67,"sixtyDayClose":5.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TARA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"TARA","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-11-10","symbol":"TARA","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2025-08-11","symbol":"TARA","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-05-08","symbol":"TARA","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2025-03-05","symbol":"TARA","fiscalQuarterEnding":"2024/12","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"pre","actualEps":-0.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TARA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TARA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1772683200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TARA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TARA","date":"2026-03-17","current":-3.896637,"percent":0.095355,"low":-7.526386,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"high":-0.187317,"avg":-1.998337,"sd":1.695881,"marketCap":293137328},"quantilePoints":[{"date":"2021-03-19","current":-5.684032,"twenty":-20.879138,"median":-9.575579,"eighty":-7.633507,"marketCap":193132023},{"date":"2021-03-26","current":-4.920653,"twenty":-20.875659,"median":-9.535146,"eighty":-7.290137,"marketCap":167193943},{"date":"2021-04-01","current":-5.14537,"twenty":-20.875659,"median":-9.513969,"eighty":-7.111164,"marketCap":174829395},{"date":"2021-04-09","current":-4.940481,"twenty":-20.875659,"median":-9.481578,"eighty":-6.977358,"marketCap":167867659},{"date":"2021-04-16","current":-5.227987,"twenty":-20.875659,"median":-9.458876,"eighty":-6.705757,"marketCap":177636546},{"date":"2021-04-23","current":-4.028392,"twenty":-20.860002,"median":-9.394803,"eighty":-6.529527,"marketCap":136876707},{"date":"2021-04-30","current":-3.697925,"twenty":-20.760843,"median":-9.36709,"eighty":-6.440704,"marketCap":125648101},{"date":"2021-05-07","current":-2.952604,"twenty":-20.680653,"median":-9.309608,"eighty":-6.319434,"marketCap":110377196},{"date":"2021-05-14","current":-2.706303,"twenty":-20.661572,"median":-9.299445,"eighty":-6.002252,"marketCap":101169740},{"date":"2021-05-21","current":-2.79341,"twenty":-20.527731,"median":-9.260889,"eighty":-5.809382,"marketCap":104426035},{"date":"2021-05-28","current":-2.847476,"twenty":-20.378122,"median":-9.211876,"eighty":-5.687069,"marketCap":106447184},{"date":"2021-06-04","current":-3.060736,"twenty":-20.29114,"median":-9.183532,"eighty":-5.642393,"marketCap":114419495},{"date":"2021-06-11","current":-2.991652,"twenty":-20.223294,"median":-9.114571,"eighty":-5.56212,"marketCap":111836915},{"date":"2021-06-18","current":-3.108795,"twenty":-20.216336,"median":-9.030689,"eighty":-5.411343,"marketCap":116216072},{"date":"2021-06-25","current":-3.072751,"twenty":-20.139792,"median":-8.980166,"eighty":-5.230317,"marketCap":114868639},{"date":"2021-07-02","current":-2.739344,"twenty":-20.026715,"median":-8.931191,"eighty":-5.176621,"marketCap":102404886},{"date":"2021-07-09","current":-2.700296,"twenty":-20.00584,"median":-8.891991,"eighty":-5.15313,"marketCap":100945167},{"date":"2021-07-16","current":-2.484032,"twenty":-19.979745,"median":-8.844309,"eighty":-5.024419,"marketCap":92860571},{"date":"2021-07-23","current":-2.517072,"twenty":-19.81448,"median":-8.831254,"eighty":-4.937837,"marketCap":94095718},{"date":"2021-07-30","current":-2.381907,"twenty":-19.57093,"median":-8.784135,"eighty":-4.916391,"marketCap":89042845},{"date":"2021-08-06","current":-1.963805,"twenty":-19.562232,"median":-8.709779,"eighty":-4.679645,"marketCap":84492697},{"date":"2021-08-13","current":-1.835844,"twenty":-19.521004,"median":-8.639802,"eighty":-4.490708,"marketCap":78987188},{"date":"2021-08-20","current":-1.781004,"twenty":-19.481695,"median":-8.568057,"eighty":-3.926608,"marketCap":76627685},{"date":"2021-08-27","current":-2.123103,"twenty":-19.423063,"median":-8.539713,"eighty":-3.689994,"marketCap":91346493},{"date":"2021-09-03","current":-2.063039,"twenty":-19.353475,"median":-8.50003,"eighty":-3.178479,"marketCap":88762274},{"date":"2021-09-10","current":-2.005588,"twenty":-19.144719,"median":-8.45468,"eighty":-3.150846,"marketCap":86290414},{"date":"2021-09-17","current":-1.890684,"twenty":-19.136021,"median":-8.381795,"eighty":-3.060736,"marketCap":81346692},{"date":"2021-09-24","current":-1.890684,"twenty":-19.049038,"median":-8.248172,"eighty":-3.024692,"marketCap":81346692},{"date":"2021-10-01","current":-1.814952,"twenty":-18.788093,"median":-8.169214,"eighty":-2.964619,"marketCap":78088330},{"date":"2021-10-08","current":-1.686992,"twenty":-18.283598,"median":-8.086205,"eighty":-2.925571,"marketCap":72582822},{"date":"2021-10-15","current":-1.786227,"twenty":-18.256054,"median":-8.072741,"eighty":-2.823446,"marketCap":76852400},{"date":"2021-10-22","current":-1.752278,"twenty":-17.634663,"median":-8.042378,"eighty":-2.796413,"marketCap":75391755},{"date":"2021-10-29","current":-1.807118,"twenty":-17.316825,"median":-8.028596,"eighty":-2.76938,"marketCap":77751258},{"date":"2021-11-05","current":-1.750374,"twenty":-16.956132,"median":-8.002536,"eighty":-2.712311,"marketCap":80223119},{"date":"2021-11-12","current":-1.799404,"twenty":-16.766857,"median":-7.944738,"eighty":-2.700296,"marketCap":82470265},{"date":"2021-11-19","current":-1.765083,"twenty":-14.709837,"median":-7.895894,"eighty":-2.640223,"marketCap":80897263},{"date":"2021-11-26","current":-1.735664,"twenty":-14.08416,"median":-7.737976,"eighty":-2.602977,"marketCap":79548975},{"date":"2021-12-03","current":-1.541996,"twenty":-13.587761,"median":-7.616501,"eighty":-2.526684,"marketCap":70672747},{"date":"2021-12-10","current":-1.664571,"twenty":-13.059936,"median":-7.304714,"eighty":-2.468413,"marketCap":76290613},{"date":"2021-12-17","current":-1.635153,"twenty":-12.58925,"median":-7.250051,"eighty":-2.347666,"marketCap":74942325},{"date":"2021-12-23","current":-1.691537,"twenty":-12.499255,"median":-7.106305,"eighty":-2.242467,"marketCap":77526543},{"date":"2021-12-31","current":-1.654765,"twenty":-12.279411,"median":-6.985495,"eighty":-2.105345,"marketCap":75841184},{"date":"2022-01-07","current":-1.537093,"twenty":-11.80201,"median":-6.968405,"eighty":-2.056772,"marketCap":70448033},{"date":"2022-01-14","current":-1.561608,"twenty":-11.502171,"median":-6.743976,"eighty":-2.017078,"marketCap":71571606},{"date":"2022-01-21","current":-1.291942,"twenty":-11.442175,"median":-6.619235,"eighty":-2.004021,"marketCap":59212302},{"date":"2022-01-28","current":-1.238009,"twenty":-11.428604,"median":-6.528996,"eighty":-1.972683,"marketCap":56740441},{"date":"2022-02-04","current":-1.345875,"twenty":-11.410034,"median":-6.498928,"eighty":-1.913142,"marketCap":61684163},{"date":"2022-02-11","current":-1.269879,"twenty":-11.375751,"median":-6.394967,"eighty":-1.890684,"marketCap":58201086},{"date":"2022-02-18","current":-1.200011,"twenty":-11.332182,"median":-6.324814,"eighty":-1.860914,"marketCap":54998903},{"date":"2022-02-25","current":-1.130143,"twenty":-11.236473,"median":-6.274206,"eighty":-1.854457,"marketCap":51796719},{"date":"2022-03-04","current":-1.061501,"twenty":-10.967917,"median":-5.983363,"eighty":-1.836366,"marketCap":48650715},{"date":"2022-03-11","current":-1.012035,"twenty":-10.816498,"median":-5.85221,"eighty":-1.828532,"marketCap":47820689},{"date":"2022-03-18","current":-1.178723,"twenty":-10.707219,"median":-5.791151,"eighty":-1.811661,"marketCap":55697038},{"date":"2022-03-25","current":-1.32398,"twenty":-10.665793,"median":-5.689093,"eighty":-1.790951,"marketCap":62560714},{"date":"2022-04-01","current":-1.195392,"twenty":-10.576512,"median":-5.676907,"eighty":-1.781252,"marketCap":56484673},{"date":"2022-04-08","current":-1.235874,"twenty":-10.470804,"median":-5.614633,"eighty":-1.765656,"marketCap":58397501},{"date":"2022-04-14","current":-1.090617,"twenty":-10.470804,"median":-5.567618,"eighty":-1.752825,"marketCap":51533825},{"date":"2022-04-22","current":-1.052517,"twenty":-10.349383,"median":-5.515493,"eighty":-1.752278,"marketCap":49733517},{"date":"2022-04-29","current":-0.871541,"twenty":-10.338669,"median":-5.389916,"eighty":-1.733213,"marketCap":41182052},{"date":"2022-05-06","current":-0.841204,"twenty":-10.302957,"median":-5.241775,"eighty":-1.720955,"marketCap":37468916},{"date":"2022-05-13","current":-0.730054,"twenty":-10.260613,"median":-5.212581,"eighty":-1.703795,"marketCap":32518069},{"date":"2022-05-20","current":-0.775525,"twenty":-10.219936,"median":-5.17692,"eighty":-1.689086,"marketCap":34543415},{"date":"2022-05-27","current":-0.881622,"twenty":-10.177293,"median":-5.1595,"eighty":-1.671323,"marketCap":39269225},{"date":"2022-06-03","current":-0.818469,"twenty":-10.175923,"median":-5.14537,"eighty":-1.654765,"marketCap":36456243},{"date":"2022-06-10","current":-0.826047,"twenty":-10.17316,"median":-5.036316,"eighty":-1.643978,"marketCap":36793801},{"date":"2022-06-17","current":-0.788155,"twenty":-10.149813,"median":-4.966918,"eighty":-1.608186,"marketCap":35106012},{"date":"2022-06-24","current":-0.858887,"twenty":-10.115699,"median":-4.937176,"eighty":-1.602303,"marketCap":38256551},{"date":"2022-07-01","current":-0.813417,"twenty":-10.081196,"median":-4.922306,"eighty":-1.571904,"marketCap":36231204},{"date":"2022-07-08","current":-0.858887,"twenty":-10.054421,"median":-4.901466,"eighty":-1.554253,"marketCap":38256551},{"date":"2022-07-15","current":-0.790681,"twenty":-10.024366,"median":-4.713617,"eighty":-1.537093,"marketCap":35218531},{"date":"2022-07-22","current":-0.826047,"twenty":-10.01091,"median":-4.632192,"eighty":-1.472373,"marketCap":36793801},{"date":"2022-07-29","current":-0.755315,"twenty":-9.999132,"median":-4.477405,"eighty":-1.344404,"marketCap":33643261},{"date":"2022-08-05","current":-0.808364,"twenty":-9.991747,"median":-4.011869,"eighty":-1.320937,"marketCap":36006166},{"date":"2022-08-12","current":-0.981378,"twenty":-9.984459,"median":-3.790456,"eighty":-1.291942,"marketCap":39548535},{"date":"2022-08-19","current":-0.922663,"twenty":-9.970692,"median":-3.692968,"eighty":-1.281211,"marketCap":37182383},{"date":"2022-08-26","current":-0.94503,"twenty":-9.93344,"median":-3.426942,"eighty":-1.268141,"marketCap":38083774},{"date":"2022-09-02","current":-0.903091,"twenty":-9.890761,"median":-3.161358,"eighty":-1.242912,"marketCap":36393666},{"date":"2022-09-09","current":-1.068052,"twenty":-9.888575,"median":-3.152348,"eighty":-1.230746,"marketCap":43041425},{"date":"2022-09-16","current":-1.023317,"twenty":-9.871082,"median":-3.108795,"eighty":-1.222062,"marketCap":41238643},{"date":"2022-09-23","current":-0.950622,"twenty":-9.803042,"median":-3.057733,"eighty":-1.196316,"marketCap":38309122},{"date":"2022-09-30","current":-0.8276,"twenty":-9.800844,"median":-3.045718,"eighty":-1.188248,"marketCap":33351471},{"date":"2022-10-07","current":-0.950622,"twenty":-9.789571,"median":-3.002165,"eighty":-1.172546,"marketCap":38309122},{"date":"2022-10-14","current":-0.928255,"twenty":-9.773183,"median":-2.964619,"eighty":-1.138478,"marketCap":37407731},{"date":"2022-10-21","current":-0.903091,"twenty":-9.74835,"median":-2.945095,"eighty":-1.10454,"marketCap":36393666},{"date":"2022-10-28","current":-0.897499,"twenty":-9.737946,"median":-2.853483,"eighty":-1.091168,"marketCap":36168318},{"date":"2022-11-04","current":-0.859898,"twenty":-9.729075,"median":-2.82645,"eighty":-1.072519,"marketCap":31999384},{"date":"2022-11-11","current":-0.790258,"twenty":-9.695318,"median":-2.820443,"eighty":-1.062085,"marketCap":29407885},{"date":"2022-11-18","current":-0.999177,"twenty":-9.680277,"median":-2.794911,"eighty":-1.038961,"marketCap":37182383},{"date":"2022-11-25","current":-1.096067,"twenty":-9.675062,"median":-2.787402,"eighty":-1.038229,"marketCap":40787948},{"date":"2022-12-02","current":-1.108178,"twenty":-9.661335,"median":-2.760369,"eighty":-1.038229,"marketCap":41238643},{"date":"2022-12-09","current":-0.932565,"twenty":-9.637158,"median":-2.722824,"eighty":-1.028704,"marketCap":34703558},{"date":"2022-12-16","current":-0.923482,"twenty":-9.600597,"median":-2.706303,"eighty":-1.026113,"marketCap":34365536},{"date":"2022-12-23","current":-0.838703,"twenty":-9.580301,"median":-2.697292,"eighty":-1.014929,"marketCap":31210667},{"date":"2022-12-30","current":-0.811453,"twenty":-9.572747,"median":-2.647731,"eighty":-1.010936,"marketCap":30196602},{"date":"2023-01-06","current":-0.905315,"twenty":-9.570858,"median":-2.632714,"eighty":-0.998153,"marketCap":33689493},{"date":"2023-01-13","current":-1.017344,"twenty":-9.549431,"median":-2.607182,"eighty":-0.988647,"marketCap":37858427},{"date":"2023-01-20","current":-0.896232,"twenty":-9.53086,"median":-2.568135,"eighty":-0.982496,"marketCap":33351471},{"date":"2023-01-27","current":-0.938621,"twenty":-9.520247,"median":-2.52308,"eighty":-0.970887,"marketCap":34928905},{"date":"2023-02-03","current":-1.020372,"twenty":-9.508129,"median":-2.484032,"eighty":-0.970887,"marketCap":37971100},{"date":"2023-02-10","current":-0.999177,"twenty":-9.49368,"median":-2.435973,"eighty":-0.975052,"marketCap":37182383},{"date":"2023-02-17","current":-0.98101,"twenty":-9.482292,"median":-2.348867,"eighty":-0.970887,"marketCap":36506340},{"date":"2023-02-24","current":-1.0234,"twenty":-9.477419,"median":-2.327841,"eighty":-0.969158,"marketCap":38083774},{"date":"2023-03-03","current":-1.171762,"twenty":-9.471834,"median":-2.166192,"eighty":-0.970541,"marketCap":43604795},{"date":"2023-03-10","current":-0.558892,"twenty":-9.454827,"median":-2.123103,"eighty":-0.968817,"marketCap":36860014},{"date":"2023-03-17","current":-0.596608,"twenty":-9.430008,"median":-2.072179,"eighty":-0.961806,"marketCap":39347500},{"date":"2023-03-24","current":-0.600037,"twenty":-9.395232,"median":-2.047371,"eighty":-0.95901,"marketCap":39573635},{"date":"2023-03-31","current":-0.536604,"twenty":-9.393279,"median":-2.022562,"eighty":-0.951269,"marketCap":35390136},{"date":"2023-04-06","current":-0.514317,"twenty":-9.39085,"median":-2.010811,"eighty":-0.950732,"marketCap":33920259},{"date":"2023-04-14","current":-0.521175,"twenty":-9.38545,"median":-2.010811,"eighty":-0.950644,"marketCap":34372529},{"date":"2023-04-19","current":-0.526318,"twenty":-9.37168,"median":-2.004282,"eighty":-0.950063,"marketCap":34711731},{"date":"2023-04-24","current":-0.601751,"twenty":-9.36709,"median":-2.002976,"eighty":-0.947826,"marketCap":39686703},{"date":"2023-05-12","current":-0.595832,"twenty":-9.357647,"median":-1.980779,"eighty":-0.944677,"marketCap":38277451},{"date":"2023-05-19","current":-0.547426,"twenty":-9.310159,"median":-1.963805,"eighty":-0.938621,"marketCap":35167761},{"date":"2023-05-26","current":-0.529824,"twenty":-9.309057,"median":-1.914187,"eighty":-0.932565,"marketCap":34036965},{"date":"2023-06-02","current":-0.491099,"twenty":-9.305817,"median":-1.899137,"eighty":-0.927924,"marketCap":31549213},{"date":"2023-06-09","current":-0.528064,"twenty":-9.300557,"median":-1.890684,"eighty":-0.923318,"marketCap":33923886},{"date":"2023-06-16","current":-0.501661,"twenty":-9.288018,"median":-1.868487,"eighty":-0.919777,"marketCap":32227691},{"date":"2023-06-23","current":-0.455913,"twenty":-9.277462,"median":-1.856736,"eighty":-0.915223,"marketCap":29288752},{"date":"2023-06-30","current":-0.404849,"twenty":-9.263177,"median":-1.854956,"eighty":-0.909758,"marketCap":26008312},{"date":"2023-07-07","current":-0.406609,"twenty":-9.242306,"median":-1.843525,"eighty":-0.908683,"marketCap":26121392},{"date":"2023-07-14","current":-0.49638,"twenty":-9.213364,"median":-1.835844,"eighty":-0.903536,"marketCap":31888452},{"date":"2023-07-21","current":-0.484059,"twenty":-9.21082,"median":-1.831927,"eighty":-0.898645,"marketCap":31096895},{"date":"2023-07-28","current":-0.466457,"twenty":-9.201982,"median":-1.814952,"eighty":-0.895009,"marketCap":29966099},{"date":"2023-08-04","current":-0.42951,"twenty":-9.176002,"median":-1.811661,"eighty":-0.884749,"marketCap":28775863},{"date":"2023-08-11","current":-0.404145,"twenty":-9.144455,"median":-1.807118,"eighty":-0.877075,"marketCap":27076501},{"date":"2023-08-18","current":-0.387235,"twenty":-9.129073,"median":-1.788838,"eighty":-0.866559,"marketCap":25943593},{"date":"2023-08-25","current":-0.366943,"twenty":-9.089591,"median":-1.782243,"eighty":-0.860504,"marketCap":24584103},{"date":"2023-09-01","current":-0.368634,"twenty":-9.075219,"median":-1.778392,"eighty":-0.858462,"marketCap":24697394},{"date":"2023-09-08","current":-0.366943,"twenty":-9.030689,"median":-1.766514,"eighty":-0.856361,"marketCap":24584103},{"date":"2023-09-15","current":-0.350034,"twenty":-9.030689,"median":-1.757501,"eighty":-0.846256,"marketCap":23451195},{"date":"2023-09-22","current":-0.30945,"twenty":-8.983309,"median":-1.752552,"eighty":-0.841204,"marketCap":20732216},{"date":"2023-09-29","current":-0.284085,"twenty":-8.979538,"median":-1.752278,"eighty":-0.837668,"marketCap":19032854},{"date":"2023-10-06","current":-0.284085,"twenty":-8.975109,"median":-1.747409,"eighty":-0.831494,"marketCap":19032854},{"date":"2023-10-13","current":-0.272231,"twenty":-8.948248,"median":-1.733213,"eighty":-0.826979,"marketCap":18238685},{"date":"2023-10-20","current":-0.255338,"twenty":-8.925505,"median":-1.724857,"eighty":-0.820995,"marketCap":17106910},{"date":"2023-10-27","current":-0.207991,"twenty":-8.92361,"median":-1.723552,"eighty":-0.82049,"marketCap":13934768},{"date":"2023-11-03","current":-0.204609,"twenty":-8.897936,"median":-1.71973,"eighty":-0.813024,"marketCap":13708186},{"date":"2023-11-10","current":-0.195533,"twenty":-8.888752,"median":-1.703795,"eighty":-0.805333,"marketCap":13524234},{"date":"2023-11-17","current":-0.18896,"twenty":-8.855549,"median":-1.691537,"eighty":-0.795229,"marketCap":13069638},{"date":"2023-11-24","current":-0.195533,"twenty":-8.843681,"median":-1.688039,"eighty":-0.792197,"marketCap":13524234},{"date":"2023-11-30","current":-0.244827,"twenty":-8.838822,"median":-1.685588,"eighty":-0.790427,"marketCap":16933705},{"date":"2023-12-08","current":-0.225109,"twenty":-8.834493,"median":-1.668711,"eighty":-0.788155,"marketCap":15569917},{"date":"2023-12-15","current":-0.2514,"twenty":-8.832064,"median":-1.664571,"eighty":-0.785629,"marketCap":17388301},{"date":"2023-12-22","current":-0.284262,"twenty":-8.808579,"median":-1.652313,"eighty":-0.780092,"marketCap":19661282},{"date":"2023-12-29","current":-0.313839,"twenty":-8.80291,"median":-1.64741,"eighty":-0.776535,"marketCap":21706964},{"date":"2024-01-05","current":-0.351631,"twenty":-8.80291,"median":-1.642508,"eighty":-0.775119,"marketCap":24320892},{"date":"2024-01-12","current":-0.391066,"twenty":-8.76536,"median":-1.610638,"eighty":-0.76542,"marketCap":27048469},{"date":"2024-01-19","current":-0.351631,"twenty":-8.759767,"median":-1.608186,"eighty":-0.750263,"marketCap":24320892},{"date":"2024-01-26","current":-0.386137,"twenty":-8.719497,"median":-1.602057,"eighty":-0.725507,"marketCap":26707522},{"date":"2024-02-02","current":-0.437074,"twenty":-8.700061,"median":-1.573865,"eighty":-0.635696,"marketCap":30230641},{"date":"2024-02-09","current":-0.474866,"twenty":-8.668425,"median":-1.565285,"eighty":-0.60758,"marketCap":32844569},{"date":"2024-02-16","current":-0.580026,"twenty":-8.627009,"median":-1.54935,"eighty":-0.596453,"marketCap":40118107},{"date":"2024-02-23","current":-0.670399,"twenty":-8.600657,"median":-1.539544,"eighty":-0.598665,"marketCap":46368804},{"date":"2024-03-01","current":-0.749269,"twenty":-8.576344,"median":-1.528513,"eighty":-0.601065,"marketCap":51823957},{"date":"2024-03-08","current":-0.62932,"twenty":-8.564197,"median":-1.50032,"eighty":-0.604837,"marketCap":43527578},{"date":"2024-03-15","current":-1.009866,"twenty":-8.558196,"median":-1.405938,"eighty":-0.604837,"marketCap":40818798},{"date":"2024-03-22","current":-1.103215,"twenty":-8.536474,"median":-1.343424,"eighty":-0.607409,"marketCap":44591964},{"date":"2024-03-28","current":-1.131503,"twenty":-8.515418,"median":-1.333505,"eighty":-0.610377,"marketCap":45735348},{"date":"2024-04-05","current":-1.13716,"twenty":-8.501975,"median":-1.314006,"eighty":-0.614401,"marketCap":45964024},{"date":"2024-04-12","current":-0.874086,"twenty":-8.491608,"median":-1.291942,"eighty":-0.61614,"marketCap":35330556},{"date":"2024-04-19","current":-0.777908,"twenty":-8.469257,"median":-1.286459,"eighty":-0.620888,"marketCap":31443051},{"date":"2024-04-26","current":-0.862771,"twenty":-8.453868,"median":-1.279685,"eighty":-0.626363,"marketCap":34873202},{"date":"2024-05-03","current":-1.400321,"twenty":-8.424307,"median":-1.286459,"eighty":-0.631322,"marketCap":59471648},{"date":"2024-05-10","current":-1.44393,"twenty":-8.381795,"median":-1.291942,"eighty":-0.635011,"marketCap":61323706},{"date":"2024-05-17","current":-1.813198,"twenty":-8.333205,"median":-1.314006,"eighty":-0.636725,"marketCap":77006510},{"date":"2024-05-24","current":-1.338082,"twenty":-8.255461,"median":-1.333505,"eighty":-0.642268,"marketCap":56828333},{"date":"2024-05-31","current":-1.362322,"twenty":-8.240074,"median":-1.338082,"eighty":-0.650353,"marketCap":57857832},{"date":"2024-06-07","current":-1.294449,"twenty":-8.202822,"median":-1.340753,"eighty":-0.657911,"marketCap":54975235},{"date":"2024-06-14","current":-1.245967,"twenty":-8.177717,"median":-1.333505,"eighty":-0.66777,"marketCap":52916238},{"date":"2024-06-21","current":-1.095676,"twenty":-8.155041,"median":-1.32398,"eighty":-0.670399,"marketCap":46533345},{"date":"2024-06-28","current":-1.008409,"twenty":-8.106451,"median":-1.311472,"eighty":-0.676971,"marketCap":42827150},{"date":"2024-07-05","current":-1.003561,"twenty":-8.090254,"median":-1.301748,"eighty":-0.688802,"marketCap":42621250},{"date":"2024-07-12","current":-1.144157,"twenty":-8.079727,"median":-1.291942,"eighty":-0.704207,"marketCap":48592343},{"date":"2024-07-19","current":-1.081131,"twenty":-8.078107,"median":-1.286459,"eighty":-0.707319,"marketCap":45915646},{"date":"2024-07-26","current":-1.139309,"twenty":-8.069522,"median":-1.283499,"eighty":-0.719847,"marketCap":48386443},{"date":"2024-08-02","current":-0.989017,"twenty":-8.06099,"median":-1.273556,"eighty":-0.728639,"marketCap":42003551},{"date":"2024-08-09","current":-0.963321,"twenty":-8.045781,"median":-1.267427,"eighty":-0.733596,"marketCap":39196566},{"date":"2024-08-16","current":-1.019092,"twenty":-8.040828,"median":-1.256237,"eighty":-0.734981,"marketCap":41465841},{"date":"2024-08-23","current":-1.100214,"twenty":-8.03286,"median":-1.245967,"eighty":-0.735628,"marketCap":44766605},{"date":"2024-08-30","current":-1.014022,"twenty":-8.027175,"median":-1.236072,"eighty":-0.739279,"marketCap":41259544},{"date":"2024-09-06","current":-0.940505,"twenty":-8.025772,"median":-1.230883,"eighty":-0.744139,"marketCap":38268227},{"date":"2024-09-13","current":-0.953181,"twenty":-8.011709,"median":-1.225752,"eighty":-0.748278,"marketCap":38783971},{"date":"2024-09-20","current":-1.003882,"twenty":-7.985479,"median":-1.219205,"eighty":-0.751381,"marketCap":40846948},{"date":"2024-09-27","current":-0.958251,"twenty":-7.958763,"median":-1.200011,"eighty":-0.753471,"marketCap":38990269},{"date":"2024-10-04","current":-0.90755,"twenty":-7.943978,"median":-1.191425,"eighty":-0.754759,"marketCap":36927291},{"date":"2024-10-11","current":-0.851779,"twenty":-7.93092,"median":-1.188248,"eighty":-0.755631,"marketCap":34658016},{"date":"2024-10-18","current":-0.968391,"twenty":-7.907232,"median":-1.181299,"eighty":-0.761589,"marketCap":39402864},{"date":"2024-10-25","current":-1.145845,"twenty":-7.874028,"median":-1.176722,"eighty":-0.766936,"marketCap":46623284},{"date":"2024-11-01","current":-1.252317,"twenty":-7.786566,"median":-1.181299,"eighty":-0.769556,"marketCap":50955536},{"date":"2024-11-08","current":-1.287808,"twenty":-7.711251,"median":-1.186406,"eighty":-0.771603,"marketCap":52399620},{"date":"2024-11-15","current":-1.211842,"twenty":-7.664281,"median":-1.188248,"eighty":-0.772699,"marketCap":50955536},{"date":"2024-11-22","current":-1.172592,"twenty":-7.610832,"median":-1.186406,"eighty":-0.772998,"marketCap":49305155},{"date":"2024-11-29","current":-1.476779,"twenty":-7.547665,"median":-1.188248,"eighty":-0.773846,"marketCap":62095613},{"date":"2024-12-06","current":-2.89959,"twenty":-7.414042,"median":-1.191425,"eighty":-0.775281,"marketCap":121921952},{"date":"2024-12-13","current":-6.827874,"twenty":-7.299855,"median":-1.200011,"eighty":-0.775525,"marketCap":287098436},{"date":"2024-12-20","current":-6.154221,"twenty":-7.287708,"median":-1.214333,"eighty":-0.776478,"marketCap":258772671},{"date":"2024-12-27","current":-6.291235,"twenty":-7.268272,"median":-1.219206,"eighty":-0.777937,"marketCap":264533843},{"date":"2025-01-03","current":-7.010559,"twenty":-7.219682,"median":-1.224859,"eighty":-0.778051,"marketCap":294780000},{"date":"2025-01-10","current":-6.348324,"twenty":-7.152861,"median":-1.228502,"eighty":-0.778051,"marketCap":266934332},{"date":"2025-01-17","current":-5.195121,"twenty":-7.017755,"median":-1.228502,"eighty":-0.778051,"marketCap":218444462},{"date":"2025-01-24","current":-5.172286,"twenty":-6.966112,"median":-1.228502,"eighty":-0.778051,"marketCap":217484267},{"date":"2025-01-31","current":-5.617582,"twenty":-6.744771,"median":-1.228502,"eighty":-0.778051,"marketCap":236208078},{"date":"2025-02-07","current":-5.035271,"twenty":-6.542798,"median":-1.228502,"eighty":-0.778051,"marketCap":211723094},{"date":"2025-02-14","current":-4.749825,"twenty":-6.427021,"median":-1.228502,"eighty":-0.778051,"marketCap":199720651},{"date":"2025-02-21","current":-4.24744,"twenty":-6.36763,"median":-1.228502,"eighty":-0.778051,"marketCap":178596351},{"date":"2025-02-28","current":-4.270276,"twenty":-6.295261,"median":-1.228502,"eighty":-0.778051,"marketCap":179556547},{"date":"2025-03-07","current":-3.314315,"twenty":-6.068849,"median":-1.226349,"eighty":-0.778051,"marketCap":147805209},{"date":"2025-03-14","current":-3.553408,"twenty":-5.896177,"median":-1.226349,"eighty":-0.778051,"marketCap":158467774},{"date":"2025-03-21","current":-3.7925,"twenty":-5.841597,"median":-1.226349,"eighty":-0.778051,"marketCap":169130339},{"date":"2025-03-28","current":-3.776011,"twenty":-5.757986,"median":-1.226349,"eighty":-0.778051,"marketCap":168394989},{"date":"2025-04-04","current":-3.215381,"twenty":-5.676349,"median":-1.226349,"eighty":-0.778051,"marketCap":143393113},{"date":"2025-04-11","current":-3.223625,"twenty":-5.615223,"median":-1.228502,"eighty":-0.778051,"marketCap":143760788},{"date":"2025-04-17","current":-3.215381,"twenty":-5.547879,"median":-1.228502,"eighty":-0.778051,"marketCap":143393113},{"date":"2025-04-25","current":-3.561652,"twenty":-5.382651,"median":-1.226349,"eighty":-0.778051,"marketCap":158835448},{"date":"2025-05-02","current":-2.951554,"twenty":-5.264428,"median":-1.226349,"eighty":-0.778051,"marketCap":131627524},{"date":"2025-05-09","current":-2.75251,"twenty":-5.197693,"median":-1.226349,"eighty":-0.778051,"marketCap":125005236},{"date":"2025-05-16","current":-2.710033,"twenty":-5.162444,"median":-1.226349,"eighty":-0.778051,"marketCap":123076142},{"date":"2025-05-23","current":-2.693042,"twenty":-5.140967,"median":-1.226349,"eighty":-0.778051,"marketCap":122304505},{"date":"2025-05-30","current":-2.65906,"twenty":-5.04362,"median":-1.226349,"eighty":-0.778051,"marketCap":120761231},{"date":"2025-06-06","current":-2.650565,"twenty":-4.951056,"median":-1.226349,"eighty":-0.778051,"marketCap":120375412},{"date":"2025-06-13","current":-2.769501,"twenty":-4.917457,"median":-1.226349,"eighty":-0.778051,"marketCap":125776873},{"date":"2025-06-20","current":-2.531629,"twenty":-4.745258,"median":-1.22605,"eighty":-0.778051,"marketCap":114973951},{"date":"2025-06-27","current":-2.531629,"twenty":-4.63767,"median":-1.22605,"eighty":-0.778051,"marketCap":114973951},{"date":"2025-07-03","current":-2.455171,"twenty":-4.496992,"median":-1.22605,"eighty":-0.778051,"marketCap":111501584},{"date":"2025-07-11","current":-2.650565,"twenty":-4.178933,"median":-1.22605,"eighty":-0.778051,"marketCap":120375412},{"date":"2025-07-18","current":-2.667556,"twenty":-3.968303,"median":-1.22605,"eighty":-0.778051,"marketCap":121147049},{"date":"2025-07-25","current":-2.837464,"twenty":-3.873228,"median":-1.22605,"eighty":-0.778051,"marketCap":128863422},{"date":"2025-08-01","current":-2.633574,"twenty":-3.784678,"median":-1.22605,"eighty":-0.778051,"marketCap":119603775},{"date":"2025-08-08","current":-2.633574,"twenty":-3.693959,"median":-1.22605,"eighty":-0.778051,"marketCap":119603775},{"date":"2025-08-15","current":-2.419805,"twenty":-3.558354,"median":-1.22605,"eighty":-0.778051,"marketCap":123076142},{"date":"2025-08-22","current":-2.351535,"twenty":-3.43929,"median":-1.22605,"eighty":-0.778051,"marketCap":119603775},{"date":"2025-08-29","current":-2.381877,"twenty":-3.370378,"median":-1.22605,"eighty":-0.778051,"marketCap":121147049},{"date":"2025-09-05","current":-2.404634,"twenty":-3.297826,"median":-1.225752,"eighty":-0.778051,"marketCap":122304505},{"date":"2025-09-12","current":-2.427391,"twenty":-3.230698,"median":-1.22605,"eighty":-0.778051,"marketCap":123461961},{"date":"2025-09-19","current":-2.434977,"twenty":-3.17084,"median":-1.22605,"eighty":-0.778051,"marketCap":123847780},{"date":"2025-09-26","current":-3.254221,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":165516192},{"date":"2025-10-03","current":-3.201122,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":162815461},{"date":"2025-10-10","current":-4.25552,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":216444251},{"date":"2025-10-17","current":-4.384475,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":223003168},{"date":"2025-10-24","current":-3.914168,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":199082413},{"date":"2025-10-31","current":-3.898997,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":198310775},{"date":"2025-11-07","current":-3.254221,"twenty":-3.13763,"median":-1.22605,"eighty":-0.778051,"marketCap":165516192},{"date":"2025-11-14","current":-3.844065,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":203354860},{"date":"2025-11-21","current":-4.697491,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":248501954},{"date":"2025-11-28","current":-5.383149,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":284773978},{"date":"2025-12-05","current":-5.011143,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":265094476},{"date":"2025-12-12","current":-5.865688,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":310300741},{"date":"2025-12-19","current":-5.055618,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":267447228},{"date":"2025-12-26","current":-5.561219,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":294194057},{"date":"2026-01-02","current":-5.399144,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":285620095},{"date":"2026-01-09","current":-5.682776,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":300624528},{"date":"2026-01-16","current":-5.105382,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":270079790},{"date":"2026-01-23","current":-5.986668,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":316700706},{"date":"2026-01-30","current":-7.090808,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":375110820},{"date":"2026-02-06","current":-6.584321,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":348317190},{"date":"2026-02-13","current":-6.614711,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":349924807},{"date":"2026-02-20","current":-7.242754,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":383148909},{"date":"2026-02-27","current":-5.844852,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":309198490},{"date":"2026-03-06","current":-5.8955,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":311877853},{"date":"2026-03-13","current":-5.009295,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":287728890},{"date":"2026-03-17","current":-5.103455,"twenty":-3.124397,"median":-1.22605,"eighty":-0.778051,"marketCap":293137328}],"updateTime":1773848621439},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TARA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148456076","title":"ArTara Therapeutics預計2026年下半年完成BCG無應答隊列入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1148456076","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148456076?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:17","pubTimestamp":1773145068,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics公司宣布，其针对BCG（卡介苗）无应答患者的Advanced-2临床试验队列，预计将于2026年下半年完成患者招募工作。这一进展标志着该公司在泌尿系统肿瘤治疗领域的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1168651837","title":"ArTara Therapeutics公司按計劃將於2026年下半年啓動針對BCG初治患者的Advanced-3註冊試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1168651837","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168651837?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:13","pubTimestamp":1773144800,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics公司正稳步推进其临床开发计划，预计在2026年下半年正式启动针对BCG初治患者群体的Advanced-3阶段注册试验。这一关键进展标志着公司在泌尿系统肿瘤治疗领域取得了重要突破。该试验旨在评估创新疗法对未接受过BCG治疗患者的疗效与安全性，其设计遵循严格的注册标准，为后续商业化申请奠定基础。若试验结果达到预期目标，将为该患者群体提供全新的治疗选择，同时有望显著提升公司在专科治疗领域的市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1131938474","title":"Protara Therapeutics公布2025年第四季度及全年財務業績並更新業務進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1131938474","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131938474?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:13","pubTimestamp":1773144782,"startTime":"0","endTime":"0","summary":"Protara Therapeutics（股票代码：TARA）近日披露了2025年第四季度及全年财务报告，同时向市场同步了公司最新业务动态。此次公告涵盖了公司在财务表现和研发进程方面的关键信息，为投资者提供了全面的运营洞察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"2616679533","title":"美國研究綜述-Crowdstrike、甲骨文、火神材料公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2616679533","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616679533?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 17:14","pubTimestamp":1772615695,"startTime":"0","endTime":"0","summary":"美国研究综述-Crowdstrike、甲骨文、火神材料公司路透3月4日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Crowdstrike、甲骨文和 Vulcan Materials。要闻 * Crowdstrike CRWD.O：伯恩斯坦将其目标价从353美元上调至368美元* NVR Inc NVR.N：Truist Securities给予该公司 \"持有 \"评级，目标价为7,700美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nL4S3ZS0Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWL","LU0757428866.USD","ACAD","TREE","BOX","LU0109392836.USD","NVR","FIGS","ORCU","ROST","MAAY","MARA","ORCL","IE00BMPRXN33.USD","LU1201861249.SGD","DHI","ARCT","ORCX","LU1935043536.SGD","CRWD","SRRK","PHM","BK5152","SGRY","GTLB","LU0476273544.USD","TARA","SPXC","VMC","HSBA.UK","LU1815336760.USD","MTH","KBH","BBY","KTB","MARO","TMHC","LU0240877869.USD","LU0234570918.USD","LU0545039389.USD","MRAL","ORCS","TEX","BK4097","LU2860962120.EUR","TGT","IMRA","LU0965508806.USD","LU0965509283.SGD","TOL"],"gpt_icon":1},{"id":"2614874530","title":"BUZZ--美國股票走勢-Henry Schein、多米諾比薩、FactSet","url":"https://stock-news.laohu8.com/highlight/detail?id=2614874530","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614874530?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 00:00","pubTimestamp":1771948829,"startTime":"0","endTime":"0","summary":"nL6N3ZK0S4 ** Kratos Defense & Security Solutions Inc KTOS.O:BUZZ - 在第一季度营收预测低于预期后下跌 nL6N3ZK0RG ** AES Corp AES.N:BUZZ - 谷歌数据中心交易后上涨   nL6N3ZK0S8 ** PPL Corp PPL.N:BUZZ--在公用事业公司出售 10 亿美元股票单位、华尔街评级提升后上涨   nL6N3ZK0SJ ** Construction Partners Inc ROAD.O:BUZZ - 由于运营实力强劲，美国银行上调了Construction Partners的PT。nL4N3ZK13K ** Larimar Therapeutics Inc LRMR.O:BUZZ - 因美国食品及药物管理局为神经系统疾病疗法贴上 \"突破性 \"标签而大涨   nL4N3ZK19H ** Consolidated Edison Inc ED.N:BUZZ - 因发行 7.77 亿美元股票而下跌   nL6N3ZK0WF ** Protara Therapeutics Inc TARA.O:BUZZ - 因癌症药物数据低于投资者预期而下跌   nL4N3ZK1CT ** Henry Schein Inc HSIC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4T3ZK1LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","OKE","NWMX","NRG","ELIS","CVS","DPZ","HSIC","ANPA","ALUR","LLII","ROAD","KTOS","PPL","LRMR","CLVT","AES","OWL","SEG","LLYZ","THR","AWI","EXPD","AMDW","WHR","ED","ITRI","KEYS","CNP","AMYY","ELIL","FRPT","KDP","VIR","ELAN","AU","PVLA","HD","FGL","BOOM","SHLS","TNC","FDS"],"gpt_icon":1},{"id":"2613717901","title":"BUZZ-抗癌藥物數據低於投資者預期，普羅塔拉股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2613717901","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613717901?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 22:12","pubTimestamp":1771942368,"startTime":"0","endTime":"0","summary":"BUZZ-抗癌药物数据低于投资者预期，普罗塔拉股价暴跌2月24日 - ** Protara Therapeutics TARA.O股价在盘前交易中下跌15.8%至6.25美元** 该药物开发商周一晚些时候称，其膀胱癌疗法TARA-002在一项正在进行的中期试验中显示，68%的患者在6个月时没有癌症迹象，但在12个月时只有33%的患者没有癌症迹象。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4T3ZK1DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1128819293","title":"Protara Therapeutics Inc：安全性及耐受性表現良好，未出現3級或以上治療相關不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1128819293","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128819293?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:11","pubTimestamp":1771884672,"startTime":"0","endTime":"0","summary":"Protara Therapeutics Inc（简称Protara）最新研究数据显示，其治疗方案展现出良好的安全性与耐受性特征。在临床试验过程中，未观察到任何3级或更高级别的治疗相关不良事件发生。这一结果进一步支持了该疗法在临床应用中的可靠性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1139200600","title":"ArTara Therapeutics, Inc.：按計劃推進於2026年下半年啓動針對BCG初治患者的Advanced-3期註冊試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1139200600","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139200600?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:11","pubTimestamp":1771884671,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics, Inc. 宣布，公司研发管线进展顺利，仍按照既定时间表推进关键临床试验。目前预计在2026年下半年，正式启动针对BCG初治患者群体的Advanced-3期注册临床试验。这一试验的启动是公司药物开发路径上的一个重要里程碑，标志着其核心候选产品向潜在获批上市又迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1183960066","title":"ArTara Therapeutics公司：預計2026年下半年完成BCG無應答隊列的Advanced-2試驗入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1183960066","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183960066?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:10","pubTimestamp":1771884619,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics公司宣布，其针对BCG无应答患者队列的Advanced-2临床试验，预计将于2026年下半年完成全部患者入组工作。该试验旨在评估公司在研疗法对于此类难治性患者群体的有效性与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1166559010","title":"Tara-002在BCG無應答非肌層浸潤性膀胱癌中展現68%的六個月完全緩解率","url":"https://stock-news.laohu8.com/highlight/detail?id=1166559010","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166559010?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:06","pubTimestamp":1771884371,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics, Inc.旗下疗法Tara-002在针对BCG无应答型非肌层浸润性膀胱癌的临床研究中，取得了令人瞩目的成果。数据显示，在为期六个月的评估期内，该疗法的完全缓解率达到了68%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1106320216","title":"Protara Therapeutics啓動靜脈氯化膽鹼三期關鍵性Thrive-3試驗 首位長期腸外營養患者完成給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1106320216","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106320216?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 21:09","pubTimestamp":1767791396,"startTime":"0","endTime":"0","summary":"生物制药公司Protara Therapeutics宣布，其针对长期肠外营养患者开展的静脉氯化胆碱三期注册性Thrive-3临床试验已完成首位患者给药。该试验旨在评估药物对肠衰竭相关肝损伤的疗效，标志着公司核心管线推进的重要里程碑。基于胆碱缺乏与肝脂肪变性病理机制的紧密关联，此次试验设计包含多重疗效终点，包括肝脏脂肪含量影像学评估与生化指标改善等核心维度。随着首位患者给药完成，后续将加速推进多中心临床入组工作，为潜在的新药申请奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TARA"],"gpt_icon":0},{"id":"1148639929","title":"Protara Therapeutics旗下Tara-002獲FDA突破性療法與快速通道雙認定 用於兒科淋巴管畸形治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1148639929","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148639929?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 21:02","pubTimestamp":1767618134,"startTime":"0","endTime":"0","summary":"Protara Therapeutics公司宣布，其研发药物Tara-002已获得美国食品药品监督管理局授予的突破性疗法认定与快速通道资格，该药物将专门用于治疗儿科患者的淋巴管畸形。这一双重认定标志着Tara-002在针对这一罕见疾病的治疗开发中取得了重要进展。淋巴管畸形是一种罕见的血管异常疾病，多发于儿童时期，目前临床治疗选择有限。随着Tara-002研发进程的推进，这一创新疗法有望为全球罹患淋巴管畸形的儿童带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"2589813891","title":"BUZZ--美國股票走勢-華納兄弟探索頻道、Ulta Beauty、維多利亞的秘密","url":"https://stock-news.laohu8.com/highlight/detail?id=2589813891","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589813891?lang=zh_tw&edition=fundamental","pubTime":"2025-12-05 22:22","pubTimestamp":1764944551,"startTime":"0","endTime":"0","summary":".N** 百度BIDU.N:BUZZ - 报道称人工智能芯片部门计划上市，港股跳涨   nL1N3XB049 ** Hewlett Packard Enterprise Co HPE.N:BUZZ - 因人工智能服务器需求疲软拖累营收前景，股价下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL4S3XB150:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2461242641.AUD","TTAN","LU0109391861.USD","INTS","LU0831093199.SGD","LUV","QCLS","LU0052750758.USD","ZUMZ","LU1366192091.USD","WBD","LU1048596156.SGD","LU0471298694.HKD","89888","LU1267930730.SGD","RGEN","VSCO","LU0496367417.USD","BK4096","CHPT","ROL","BK4097","LU2357305700.SGD","RBRK","HPE","TRMB","PSN","COO","BK4023","IOT","ULTA","LU0630378692.HKD","PKG","SW","SGXZ23171101.USD","S","TARA","LU1015430645.USD","LU2778985437.USD","SWR.UK","LU0531971595.HKD","BMEA","LU0630378429.USD"],"gpt_icon":1},{"id":"2589585288","title":"BUZZ-生物技術公司 Protara 計劃融資 7500 萬美元，股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2589585288","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589585288?lang=zh_tw&edition=fundamental","pubTime":"2025-12-05 06:15","pubTimestamp":1764886534,"startTime":"0","endTime":"0","summary":"BUZZ-生物技术公司 Protara 计划融资 7500 万美元，股价暴跌12月4日 - ** Protara Therapeutics TARA.O股价盘后下跌12%，至6.05美元，原因是该公司正在寻求股本** 该公司开始  7500 万美元的发行，包括股票和预先筹资的认股权证。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4S3XA1O7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDRTCR15.USD","LU0976567544.SGD","LU1116320737.USD","LU2357305700.SGD","LU2462157665.USD","LU0070302665.USD","LU0496365809.HKD","LU2237443382.USD","LU0868494617.USD","LU1974910355.USD","LU0310799852.SGD","IE00BYXW3230.USD","LU0149725797.USD","LU1244550221.USD","BK4139","LU0265550946.USD","BK4516","BK4534","LU0820561909.HKD","LU2417539215.USD","LU1244550494.USD","PIPR","LU0256863811.USD","LU0417517546.SGD","LU2237443549.SGD","LU0238689110.USD","LU2023250504.SGD","LU2211815571.USD","TARA","BK4533","LU0964807845.USD","LU1670628061.USD","LU2242649171.HKD","BK4585","SG9999002232.USD","SG9999002224.SGD","LU2213496289.HKD","IE0034235303.USD","LU0265550359.USD","LU1366192091.USD","LU1894683348.USD","LU0323591593.USD","BK4581","LU1119994496.HKD","LU0211328371.USD","LU2237443622.USD","LU2237443978.SGD","LU0971096721.USD","LU2237443895.HKD","LU0882574139.USD"],"gpt_icon":0},{"id":"1173704020","title":"ArTara Therapeutics, Inc.：Tara-002在BCG未治療患者的12個月裏顯示出50%的完全反應率","url":"https://stock-news.laohu8.com/highlight/detail?id=1173704020","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173704020?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 21:20","pubTimestamp":1764768013,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics, Inc.：Tara-002在BCG未治疗患者的12个月里显示出50%的完全反应率","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1191729606","title":"Protara Therapeutics: Tara-002在BCG未治療患者中的完全緩解率高達72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191729606","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191729606?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 21:15","pubTimestamp":1764767718,"startTime":"0","endTime":"0","summary":"Protara Therapeutics: Tara-002在BCG未治疗患者中的完全缓解率高达72%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TARA"],"gpt_icon":0},{"id":"1160877626","title":"Protara Therapeutics公布積極的中期結果，顯示在對患有淋巴畸形的兒童患者進行的Phase 2 Starborn-1試驗中Tara-002的強烈反應","url":"https://stock-news.laohu8.com/highlight/detail?id=1160877626","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160877626?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 21:01","pubTimestamp":1763557277,"startTime":"0","endTime":"0","summary":"Protara Therapeutics公布积极的中期结果，显示在对患有淋巴畸形的儿童患者进行的Phase 2 Starborn-1试验中Tara-002的强烈反应","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1106440511","title":"ArTara Therapeutics, Inc.：88%的患者在接受一劑或兩劑Tara-002治療後取得臨床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=1106440511","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106440511?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 21:01","pubTimestamp":1763557273,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics, Inc.：88%的患者在接受一剂或两剂Tara-002治疗后取得临床成功","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0},{"id":"1176687264","title":"ArTara Therapeutics, Inc.: Tara-002顯示出良好的安全性和耐受性，無嚴重不良事件報告","url":"https://stock-news.laohu8.com/highlight/detail?id=1176687264","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176687264?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 21:01","pubTimestamp":1763557271,"startTime":"0","endTime":"0","summary":"ArTara Therapeutics, Inc.: Tara-002显示出良好的安全性和耐受性，无严重不良事件报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}